Otsuka Holdings Co., Ltd.
4578Pharmaceuticals
¥12,285.00+1.15%As of Oct 29vs prior close
- Market cap
- $40.7B
- P/E (TTM)
- 15.9×
- P/E (FY1)
- 17.5×
- From 52W high
- −3.31%
- EPS (LTM)
- ¥764.96
- Revenue (LTM)
- ¥2.6T
- Net margin
- 15.46%
- Dividend yield
- 1.38%
Nomior Score
63
Steady ProfileTop 21% of the scored universe
Growth38
Quality55
Value48
Momentum92
Resilience58
Growth
+12.41%revenue a year over 3 fiscal years
YE22 ¥1.7TLTM ¥2.6T
Connections
Revenue to profitYE25
15% of revenue became net profit.